Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Lymphangioleiomyomatosis Sirolimus Trial for Safety (MLSTS)
jRCT2091220096Completed
- Sponsor
- Koh Nakata, MD, PhD
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sirolimus in lymphangioleiomyomatosis (LAM), sponsored by Koh Nakata, MD, PhD. Primary endpoint: All adverse events. Started Aug 2012; status: completed.
02
Drugs
sirolimus
03
Conditions
lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on jRCT2091220096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220096.